Replies to post #238991 on Avid Bioservices Inc (CDMO)

[realist1]

A few points:

1. Funny that PPHM ran trials for YEARS and never mentioned PD-L-1 as an aspect of them until recently. It shows how truly fumbling in the dark they are.

2. Funny that everyone cheered (as always) when the trial with Opdivo was announced. Now the trial with Opdivo is trashed and everyone cheers again. Bizarre.

3. Is it "news" to dump 1 trial and start another? Simply MORE wasted time. And as should be painfully obvious with the destructive dilution, time = cash burned = more shares for nothing.

The simple conclusion?
MORE YEARS of trials = more years of cash burn = more years of dilution = this stocks long term down trend will remain intact.

[jakedogman1]

interesting developments... wonder what impact berman had on this..

note the utsw connections and note the lawsuits with bms going after berman

http://www.biospace.com/News/dr-david-berman-joins-medimmune-as-head-of/385141

http://www.fiercebiotech.com/story/bristol-myers-fires-lawsuit-sideline-rd-defector-headed-rival-astrazeneca/2015-06-01

AZN market cap $80 bil and BMy market cap $104 bil....